| Literature DB >> 29884161 |
Amutha Ramadas1, Carina Ka Yee Chan2, Brian Oldenburg3, Zanariah Hussein4, Kia Fatt Quek5.
Abstract
BACKGROUND: Increasing prevalence and disease burden has led to an increasing demand of programs and studies focused on dietary and lifestyle habits, and chronic diseases such as type 2 diabetes mellitus (T2DM). We evaluated the effects of a 6-month web-based dietary intervention on Dietary Knowledge, Attitude and Behaviour (DKAB), Dietary Stages of Change (DSOC), fasting blood glucose (FBG) and glycosylated haemoglobin (HbA1c) in patients with uncontrolled HbA1c (> 7.0%) in a randomised-controlled trial (myDIDeA) in Malaysia.Entities:
Keywords: Diabetes mellitus, type 2; Diet therapy; Randomised-controlled trial; Telemedicine
Mesh:
Substances:
Year: 2018 PMID: 29884161 PMCID: PMC5994015 DOI: 10.1186/s12889-018-5640-1
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Study flow chart
Eligibility criteria used in the screening of the participants
| Inclusion | Exclusion |
|---|---|
| • Mentally sound men and women who are ≥ 18 years old. | • Are pregnant, lactating or intend to become pregnant during the study period. |
Sample of the lesson plans
| Lesson plan | General recommendations | Intervention objectives | Patient’s objectives |
|---|---|---|---|
| Sugar | • Total free sugar not > 10% unless if the glucose level is under control. | • Educate on various other forms of sugar in food products. | • Able to identify and reduce consumption of common food products that are high in hidden sugar. |
| Fruits & vegetables | • 5–7 servings of fruits and vegetables a day. | • Consume fruits and vegetables as whole whenever possible. | • Include fruits and vegetables in main meals or as snacks to achieve the recommended servings per day. |
| Eating out habit | • Maintain healthy eating outside home. | • Encourage to choose sugar-free or sugar-less meals. | • Reduce consumption of artificial flavouring such as sauces, dressings, salt or sugar when eating out. |
Demography and baseline characteristics of the study participants
| e-intervention | control | Total | ||
|---|---|---|---|---|
| n = 66 | n = 62 | N (%) | ||
| Demographic characteristics | ||||
| Age | 49.6 (10.7) | 51.5 (10.3) | 50.5 (10.5) | |
| Gender | % male | 62.1 | 75.8 | 60.2 |
| Ethnic group | % Malay | 69.7 | 75.8 | 72.6 |
| Education | % tertiary | 62.1 | 54.8 | 61.7 |
| Occupation | % employed | 68.2 | 54.8 | 61.7 |
| Personal income (MYR) | 4837 (2571) | 4813 (4672) | 5166 (3816) | |
| Medical condition | ||||
| Diabetes duration (months) | 111.1 (106.3) | 81.8 (69.9) | 96.9 (91.3) | |
| Family history of diabetes | % yes | 84.8 | 82.3 | 83.6 |
| Diabetes medication | OHA | 48.5 | 50.0 | 49.3 |
| Insulin only | 10.6 | 3.2 | 7.0 | |
| OHA + insulin | 37.9 | 35.5 | 36.7 | |
| Unknown | 3.0 | 11.3 | 7.0 | |
| Self-monitor blood glucose | Daily | 9.1 | 14.5 | 11.7 |
| 4–6 times/week | 13.6 | 1.6 | 1.7 | |
| 1–3 times/week | 71.2 | 53.2 | 62.5 | |
| Less than once a week | 3.0 | 6.5 | 4.7 | |
| No | 15.2 | 24.2 | 19.5 | |
| Self-reported clinical history | Hypoglycaemia | 7.6 | 3.2 | 5.5 |
| Heart disease | 6.1 | 14.5 | 10.2 | |
| Kidney disease | 1.5 | 0.0 | 0.8 | |
| Nerve disorder | 3.0 | 8.1 | 5.5 | |
| Hypertension | 54.5 | 48.4 | 53.1 | |
| Dyslipidaemia | 48.5 | 43.5 | 46.1 | |
| Lifestyle | ||||
| Total MET/weeka,b | 879.0 (269.5) | 620.3 (335.7) | 733.0 (213.2) | |
| Physical activity level | Low | 37.9 | 50.0 | 43.8 |
| Moderate | 39.4 | 30.6 | 35.2 | |
| High | 22.7 | 19.4 | 21.0 | |
| Smoking | % yes | 13.6 | 17.7 | 15.6 |
| Alcohol drinking | % yes | 10.6 | 4.8 | 7.8 |
|
| ||||
| Total DKAB score | 34.2 (5.2) | 33.7 (5.5) | 33.9 (5.4) | |
| Total DSOC score | 193.3 (14.6) | 191.2 (16.2) | 192.3 (15.4) | |
|
| ||||
| Fasting blood glucose (mmol/L) | 8.9 (3.9) | 8.3 (2.9) | 8.6 (3.5) | |
| HbA1c (%) | 9.1 (2.0) | 8.9 (1.9) | 9.0 (2.0) | |
Data are presented as means (SD) and percentages, or as amedians (SE) for skewed data
bAssessed based on International Physical Activity Questionnaire (IPAQ)
Two-tailed independent t-test (or Mann Whitney Rank Test) and chi-square analysis (or Fisher Exact Test) were performed between study groups. None of the analysis were significant at p < 0.05
Within and between study groups comparison at various data collection points
| Timeline (month) | Within study group | Between study groups | Interaction (Timeline*study group) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 6th | 12th | F | P | ƞ2 | F | P | ƞ2 | F | P | ƞ2 | ||
| Total DKAB score | e-intervention | 34.2 (5.2) | 45.2 (8.0) | 54.0 (8.7) | 244.212 | < 0.001** | 0.790 | 26.818 | < 0.001** | 0.175 | 53.059 | < 0.001** | 0.296 |
| Control | 33.7 (5.5) | 40.2 (9.9) | 41.3 (7.7) | 62.453 | < 0.001** | 0.676 | |||||||
|
| e-intervention | 5.8 (2.1) | 8.1 (2.2) | 8.5 (2.0) | 102.738 | < 0.001** | 0.612 | 12.027 | < 0.001** | 0.087 | 23.824 | < 0.001** | 0.159 |
| Control | 5.9 (1.7) | 6.7 (1.6) | 6.8 (1.5) | 13.540 | < 0.001** | 0.182 | |||||||
|
| e-intervention | 23.7 (4.1) | 30.8 (6.2) | 38.2 (6.7) | 221.521 | < 0.001** | 0.773 | 21.680 | < 0.001** | 0.147 | 38.478 | < 0.001** | 0.234 |
| Control | 23.0 (4.3) | 27.3 (8.6) | 29.1 (6.7) | 38.318 | < 0.001** | 0.618 | |||||||
|
| e-intervention | 4.7 (1.8) | 6.3 (2.1) | 7.2 (2.0) | 103.180 | < 0.001** | 0.614 | 9.076 | 0.003* | 0.067 | 27.205 | < 0.001** | 0.178 |
| Control | 4.7 (2.1) | 5.2 (2.1) | 5.4 (2.1) | 6.168 | 0.004* | 0.092 | |||||||
| DSOC score | e-intervention | 193.3 (14.6) | 197.5 (16.7) | 199.7 (18.2) | 3.305 | 0.046* | 0.049 | 7.552 | 0.007* | 0.057 | 1.488 | 0.229 | 0.012 |
| Control | 191.2 (16.2) | 191.2 (17.1) | 191.5 (15.1) | 0.008 | 0.992 | 0.000 | |||||||
| FBG (mmol/L) | e-intervention | 8.9 (3.9) | 8.1 (2.7) | 7.9 (2.5) | 6.054 | 0.015* | 0.085 | 0.899 | 0.345 | 0.007 | 0.591 | 0.453 | 0.005 |
| Control | 8.3 (2.9) | 7.6 (2.6) | 7.7 (2.6) | 2.501 | 0.117 | 0.039 | |||||||
| HbA1c (%) | e-intervention | 9.1 (2.0) | 8.7 (1.9) | 8.5 (1.8) | 8.334 | 0.004* | 0.114 | 0.433 | 0.511 | 0.003 | 0.793 | 0.383 | 0.006 |
| Control | 8.9 (1.9) | 8.3 (2.1) | 8.4 (2.2) | 10.934 | 0.001* | 0.152 | |||||||
Data expressed as mean (SD); e-intervention (n = 66) and control (n = 62)
*significant at p < 0.05; **significant at p < 0.001
Fig. 2Changes in mean DKAB score and its sub-domains (a-d), (e) DSOC score, (f) FBG(mmol/L) and (g) HbA1c(%) across data collection points